Blueprint Medicines
BPMC
#2504
Rank
S$7.38 B
Marketcap
$115.50
Share price
-0.49%
Change (1 day)
-3.03%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$12.38

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$12.24. In 2022 the company made an earnings per share (EPS) of -$12.46 an increase over its 2021 EPS that were of -$14.63.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.38-0.6%
2022-$12.46-14.85%
2021-$14.63-297.13%
2020$7.42-176.3%
2019-$9.7335.19%
2018-$7.1938.82%
2017-$5.1847.35%
2016-$3.529.25%
2015-$3.22-31.35%
2014-$4.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.09327-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.36-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.69-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA